<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21952871</PMID><DateCompleted><Year>2012</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>259</Volume><Issue>4</Issue><PubDate><Year>2012</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Difference in chronological changes of outcome measures between untreated and placebo-treated patients of spinal and bulbar muscular atrophy.</ArticleTitle><Pagination><StartPage>712</StartPage><EndPage>719</EndPage><MedlinePgn>712-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-011-6251-2</ELocationID><Abstract><AbstractText>Spinal and bulbar muscular atrophy (SBMA) is an adult-onset, X-linked motor neuron disease characterized by muscle atrophy, weakness, and bulbar involvement. The aim of this study was to analyze the differential change of various outcome measures by comparing the progression of motor impairment in the two independent groups: placebo-treated group (PTG) and natural history group (NHG). For the PTG, we analyzed 99 patients who participated in a previous double-blind phase III clinical trial and received placebo. For the NHG, a total of 34 patients were followed with no specific treatment. The characteristics of both groups did not differ at baseline except for disease duration. Although the 6&#xa0;min walk distance (6MWD) showed almost the same progression in both groups (-14.7&#xa0;&#xb1;&#xa0;7.3&#xa0;m in NHG, -14.0&#xa0;&#xb1;&#xa0;4.7&#xa0;m in PTG; NS), there was a significant difference of progression in the ALSFRS-R between the NHG and PTG (-1.18&#xa0;&#xb1;&#xa0;0.38, -0.14&#xa0;&#xb1;&#xa0;0.24; p&#xa0;=&#xa0;0.03). A similar tendency was also seen in the subgroup analysis of the patients whose disease durations were less than 10&#xa0;years. Although the relationship between the ALSFRS-R and 6MWD at week 48 was similar to that at baseline in the NHG, the slope of the regression at week 48 was significantly milder than at baseline in the PTG (p&#xa0;=&#xa0;0.04). In conclusion, these two groups demonstrated a large difference in the chronological analysis of a motor function score, but showed similar changes in objective measures of walking capacity. These findings should be thoroughly considered when designing clinical trials for slowly progressive neurodegenerative diseases such as SBMA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hashizume</LastName><ForeName>Atsushi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsuno</LastName><ForeName>Masahisa</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Banno</LastName><ForeName>Haruhiko</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Keisuke</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Suga</LastName><ForeName>Noriaki</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Fumiaki</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Sobue</LastName><ForeName>Gen</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017326" MajorTopicYN="N">Clinical Trials, Phase III as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015990" MajorTopicYN="Y">Placebo Effect</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011597" MajorTopicYN="N">Psychomotor Performance</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016138" MajorTopicYN="N">Walking</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21952871</ArticleId><ArticleId IdType="doi">10.1007/s00415-011-6251-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nature. 1991 Jul 4;352(6330):77-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2009 Feb;65(2):140-50</Citation><ArticleIdList><ArticleId IdType="pubmed">19259967</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Sci. 1993 Jul;117(1-2):74-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8410070</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 2001 Jan;70(1):70-3</Citation><ArticleIdList><ArticleId IdType="pubmed">11118250</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2002 Aug 29;35(5):855-64</Citation><ArticleIdList><ArticleId IdType="pubmed">12372281</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2001 May 24;344(21):1594-602</Citation><ArticleIdList><ArticleId IdType="pubmed">11372012</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 1989 Feb;112 ( Pt 1):209-32</Citation><ArticleIdList><ArticleId IdType="pubmed">2917278</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2006 Jun;129(Pt 6):1446-55</Citation><ArticleIdList><ArticleId IdType="pubmed">16621916</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1968 Jul;18(7):671-80</Citation><ArticleIdList><ArticleId IdType="pubmed">4233749</ArticleId></ArticleIdList></Reference><Reference><Citation>No To Shinkei. 2001 Apr;53(4):346-55</Citation><ArticleIdList><ArticleId IdType="pubmed">11360474</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2009 Feb 17;72(7 Suppl):S51-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19221315</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2010 Apr;11(4):247-58</Citation><ArticleIdList><ArticleId IdType="pubmed">20177426</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2008 Aug 26;71(9):677-84</Citation><ArticleIdList><ArticleId IdType="pubmed">18725593</ArticleId></ArticleIdList></Reference><Reference><Citation>Amyotroph Lateral Scler. 2010 May 3;11(3):266-71</Citation><ArticleIdList><ArticleId IdType="pubmed">19961264</ArticleId></ArticleIdList></Reference><Reference><Citation>No To Shinkei. 2004 Jun;56(6):483-94</Citation><ArticleIdList><ArticleId IdType="pubmed">15328837</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2004 May 19;24(20):4778-86</Citation><ArticleIdList><ArticleId IdType="pubmed">15152038</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2010 Sep;9(9):875-84</Citation><ArticleIdList><ArticleId IdType="pubmed">20691641</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2006 Mar;59(3):520-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16358333</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Brain Res. 2009;175:283-94</Citation><ArticleIdList><ArticleId IdType="pubmed">19660663</ArticleId></ArticleIdList></Reference><Reference><Citation>Muscle Nerve. 2008 Aug;38(2):964-71</Citation><ArticleIdList><ArticleId IdType="pubmed">18642379</ArticleId></ArticleIdList></Reference><Reference><Citation>Amyotroph Lateral Scler. 2010 Oct;11(5):456-60</Citation><ArticleIdList><ArticleId IdType="pubmed">20565333</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2002 Aug 29;35(5):843-54</Citation><ArticleIdList><ArticleId IdType="pubmed">12372280</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1983 Oct;33(10):1316-21</Citation><ArticleIdList><ArticleId IdType="pubmed">6684226</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2003 Jun;9(6):768-73</Citation><ArticleIdList><ArticleId IdType="pubmed">12754502</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2010 Mar 9;74(10):833-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20211907</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Neurol. 2002 Dec;59(12):1921-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12470181</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2007 Dec;6(12):1045-53</Citation><ArticleIdList><ArticleId IdType="pubmed">17980667</ArticleId></ArticleIdList></Reference><Reference><Citation>Disabil Rehabil. 2005 Nov 30;27(22):1365-71</Citation><ArticleIdList><ArticleId IdType="pubmed">16372431</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2002 Sep 10;59(5):770-2</Citation><ArticleIdList><ArticleId IdType="pubmed">12221177</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol. 1999 Nov;246 Suppl 3:III16-21</Citation><ArticleIdList><ArticleId IdType="pubmed">10631656</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 1992 Nov;32(5):707-10</Citation><ArticleIdList><ArticleId IdType="pubmed">1449253</ArticleId></ArticleIdList></Reference><Reference><Citation>J Inherit Metab Dis. 1997 Jun;20(2):152-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9211187</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Neurol. 1996 Feb;53(2):141-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8639063</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>